TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
133.30
-5.99 (-4.30%)
At close: Feb 11, 2026, 4:00 PM EST
134.00
+0.70 (0.53%)
After-hours: Feb 11, 2026, 6:38 PM EST

TransMedics Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
4,5552,0932,5771,970532541
Market Cap Growth
102.51%-18.80%30.78%270.34%-1.57%37.38%
Enterprise Value
4,6092,2812,6651,834464442
Last Close Price
133.3062.3578.9361.7219.1619.90
PE Ratio
52.5659.01----
Forward PE
51.6756.70----
PS Ratio
7.964.7410.6721.0817.5821.08
PB Ratio
12.819.1518.7810.527.845.20
P/TBV Ratio
13.339.7420.9710.527.845.20
P/OCF Ratio
25.5942.88----
EV/Sales Ratio
8.145.1711.0319.6215.3417.25
EV/EBITDA Ratio
38.2339.83307.71---
EV/EBIT Ratio
48.0360.825495.72---
Debt / Equity Ratio
1.462.273.760.360.650.33
Debt / EBITDA Ratio
4.078.1938.35---
Asset Turnover
0.650.590.490.450.210.20
Inventory Turnover
4.663.952.701.590.680.78
Quick Ratio
6.867.258.349.674.2311.16
Current Ratio
7.698.309.3010.665.1112.36
Return on Equity (ROE)
32.48%19.39%-15.42%-28.39%-51.49%-36.27%
Return on Assets (ROA)
6.93%3.10%0.06%-9.54%-17.18%-12.82%
Return on Invested Capital (ROIC)
22.45%11.12%0.31%-86.19%-245.59%-251.12%
Return on Capital Employed (ROCE)
11.10%5.00%0.10%-12.40%-35.30%-18.80%
Earnings Yield
2.01%1.70%-0.97%-1.84%-8.31%-5.32%
FCF Yield
2.65%-3.87%-6.40%-2.93%-6.09%-5.68%
Buyback Yield / Dilution
-13.12%-8.30%-10.02%-7.02%-11.80%-73.91%
Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q